Immunohistochemical localizations of secretin, cholecystokinin, and somatostatin in the rat small intestine after acute cisplatin treatment

Experimental and Molecular Pathology

Volumn 77, Issue 3, 2004, Pages 238-245

  Miyamoto, Yohei ^a   Miyamoto, Mari ^a  

^a TORAY INDUSTRIES INC   (Japan)

Author keywords

Cholecystokinin (CCK); Cisplatin (CDDP); Gut mucosal toxicity; Immunohistochemistry; Secretin; Small intestine; Somatostatin

Indexed keywords

AVIDIN; BIOTIN; CHOLECYSTOKININ; CISPLATIN; GASTRIN; GASTROINTESTINAL HORMONE; PARAFFIN; PEROXIDASE; PROTEIN ANTIBODY; SECRETIN; SODIUM CHLORIDE; SOMATOSTATIN; SOMATOSTATIN ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL COUNT; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DUODENUM; EUTHANASIA; EXPERIMENTAL RAT; GASTROINTESTINAL TOXICITY; ILEUM; IMMUNOCOMPETENT CELL; IMMUNOHISTOCHEMISTRY; IMMUNOPEROXIDASE STAINING; JEJUNUM; MALE; NEPHROTOXICITY; NONHUMAN; PROTEIN ANALYSIS; PROTEIN DETERMINATION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN SECRETION; RAT; RAT STRAIN; SMALL INTESTINE;

ANIMALS; ANTINEOPLASTIC AGENTS; BLOOD UREA NITROGEN; CELL COUNT; CHOLECYSTOKININ; CISPLATIN; CREATININE; IMMUNOENZYME TECHNIQUES; INJECTIONS, INTRAVENOUS; INTESTINAL MUCOSA; INTESTINE, SMALL; MALE; RATS; RATS, SPRAGUE-DAWLEY; SECRETIN; SOMATOSTATIN; TIME FACTORS;

EID: 7044262094     PISSN: 00144800     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yexmp.2004.05.007     Document Type: Article

References (29)

1. Allan S.G., Smyth J.F. Small intestinal mucosal toxicity of cis-platinum: comparison of toxicity with platinum analogues and dexamethasone. Br. J. Cancer. 53:1986;355-360
2. Ardaillou R., Paillard F. Metabolism of polypeptide hormones by the kidney. Hamburger J., Crosnier J., Grunfeld J.P., Maxwell M.H. Advance in Nephrology. 1980;247-269 Year Book Medical Publishers, Chicago
3. Blisard K.S., Harrington K.A., Long D.A., Jackson J.E. Relative lack of toxicity of transplatin with cisplatin in rodents. J. Comp. Pathol. 105:1991;367-375
4. Choie D.D., Longnecker D.S., Del Campo A.A. Acute and chronic cisplatin nephropathy in rats. Lab. Invest. 44:1981;397-402
5. Choie D.D., Longnecker D.S., Copley M.P. Cytotoxicity of cisplatin in rat intestine. Toxicol. Appl. Pharmacol. 60:1981;354-359
6. Chopra S., Kaufman J.S., Jones T.W., Hong W.K., Gehr M.K., Hamburger R.J., Trump B.F. Cis-diamminedichloroplatinum-induced acute renal failure in the rat. Kidney Int. 21:1982;54-64
7. Davis S., Kessler W., Haddad B.M., Maesaka J.K. Acute renal tubular dysfunction following cis-dichlorodiammine platinum therapy. J. Med. 11:1980;133-141
8. Dentino M., Luft F.C., Yum M.N., Williams S.D., Einhorn L.H. Long term effect of cis-diamminedichloride platinum (CDDP) on renal function and structure in man. Cancer. 41:1978;1274-1281
9. Dileepan K.N., Wagle S.R. Somatostatin: a metabolic regulator. Life Sci. 23:1985;2335-2343
10. Dobyan D.C., Levi J., Jacobs C., Kosek J., Weiner M.W. Mechanism of cisplatinum nephrotoxicity: II. Morphologic observations. J. Pharmacol. Exp. Ther. 213:1980;551-556
11. Douple E.B. Cis-diamminedichloroplatinum (II): effects of a representative metal coordination complex on mammalian cells. Pharamacol. Ther. 25:1984;197-326
12. Fine H., levine G.M., Shiau Y.-F. Effects of cholecystokinin and secretin on intestinal structure and function. Am. J. Physiol. 245:1983;G358-G363
13. Grekas D.M., Raptis S., Tourkantonis A.A. Plasma secretin, pancreozymin, and somatostatin-like hormone in chronic renal failure patients. Uremia Invest. 8:1984-1985;117-120
14. Hardaker W.T., Stone R.A., McCoy R. Platinum nephrotoxicity. Cancer. 34:1974;1030-1032
15. Hill J.M., Lobe E., MacLellan A., Hill N.O., Khan A., King J.J. Clinical studies of platinum coordination compounds in the treatment of various malignant diseases. Cancer Treat. Rep. 59:1975;647-659
16. Jones T.W., Chopra S., Kaufman J.S., Flamenbaum W., Trump B.F. Cis-diamminedichlorplatinum II-induced acute renal failure in the rat. Lab. Invest. 52:1985;363-374
17. Kodama O. Experimental studies on pathogenic mechanisms and effects of exogenous secretin in acute hemorrhagic gastroduodenal ulcer. Especially on the ulcerogenic factors and anti-ulcerogenic actions of exogenous secretin in rats with acute renal failure and obstructive jaundice. Hiroshima J. Med. Sci. 29:1981;151-189
18. Macleod P.M., Tyrell C.J., Keeling D.H. The effect of cisplatin on renal function in patients with testicular tumors. Clin. Radiol. 39:1988;190-192
19. Morisset J., Genik P. Effects of acute and chronic administration of secretion and caerulein on rat duodenal and gastric growth. Regul. Pept. 5:1983;111-123
20. Nosaka K., Nakada J., Endou H. Cisplatin-induced alterations in renal structure, ammoniagenesis and glucogenesis of rats. Kidney Int. 41:1992;73-79
21. Rabkin R. Role of the kidney in hormone metabolism. Massry S.G., Glassock R.J. Textbook Nephrology. 1984;2.3-2.10 Williams and Wilkins, Baltimore
22. Rosenberg B. Fundamental studies with cisplatin. Cancer. 55:1985;2303-2316
23. Schaeppi U., heyman L.A., Fleischman R.W., Rosenkrantz H., Ilievski V., Phelan R., Cooney D.A., Davis R.D. Cis-Dichlorodiammine-platinum (II) (NSC-119875): preclinical toxicologic evaluation of intravenous injection in dogs, monkeys, and mice. Toxicol. Appl. Pharmacol. 25:1973;230-241
24. Tally R.W., Bryan R.M., Gutterman J.U., Brownlee R.W., McCredie K.B. Clinical evaluation of toxic effects of cis-diammine-dichloroplatinum (II) in man. Cancer Treat. Rep. 57:1973;465-471
25. Tay L.K., Bregman C.L., Maters B.A., Williams P.D. Effects of cis-diamminedichloroplatinum (II) on rabbit kidney in vivo and on rabbit renal proximal tubule cells in culture. Cancer Res. 48:1988;2538-2543
26. 2-microglobulin-uria during cisplatinum treatment. Eur. J. Clin. Pharmacol. 29:1985;313-318
27. Von Hoff D.D., Schilsky R., Reichert C.M., Reddick R.L., Rozencweig M., Young R.C., Muggia F.M. Toxic effects of cis-dichlorodiammineplatinum (II) in man. Cancer Treat. Rep. 63:1979;1527-1531
28. Ward J.M., Fauvie K.A. The nephrotoxic effects of cis- diamminedichlorplatinum (II) (NSC-119875) in male F344 rats. Toxicol. Appl. Pharmacol. 38:1976;535-547
29. Weser E., Bell D., Tawil T. Effects of octapeptide-cholecystokinin, secretin, and glucagon on intestinal mucosal growth in parenterally nourished rats. Dig. Dis. Sci. 26:1981;409-416